Vertex Pharmaceuticals (VRTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 206 |
| % of all portfolios: | 0.041% |
| Hold Price * : | $465.06 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Torray Funds | Add 13.01% | 1,813 | 0.12 | |
| ≡ | John Armitage - Egerton Capital | Buy | 124,045 | 0.58 | |
| Q2 2024 | |||||
| ≡ | Torray Funds | Add 0.28% | 39 | 0.00 | |
| Q4 2023 | |||||
| ≡ | Torray Funds | Buy | 14,068 | 0.93 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,457 | 0.01 | |
| Q4 2021 | |||||
| ≡ | Tweedy Browne Co. - Tweedy Browne Value Fund | Buy | 23,825 | 1.26 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 18,052 | 0.04 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 6,254 | 0.01 | |
| Q1 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 460 | 0.00 | |
| Q1 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 524,867 | 1.00 | |
| Q1 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 95,000 | 0.03 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.